Lpl Financial LLC Intra Cellular Therapies, Inc. Transaction History

Lpl Financial LLC

  • $218 Billion
  • Q3 2024

A detailed history of Lpl Financial LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 20,380 shares of ITCI stock, worth $1.76 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,380
Previous 10,560 92.99%
Holding current value
$1.76 Million
Previous $723,000 106.09%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
BUY
$67.99 - $80.84 $667,661 - $793,848
9,820 Added 92.99%
20,380 $1.49 Million
Q2 2024

Aug 07, 2024
BUY
$64.76 - $79.84 $88,462 - $109,061
1,366 Added 14.86%
10,560 $723,000
Q1 2024

May 10, 2024
BUY
$64.37 - $75.65 $17,122 - $20,122
266 Added 2.98%
9,194 $636,000
Q4 2023

Feb 14, 2024
SELL
$46.37 - $73.65 $21,422 - $34,026
-462 Reduced 4.92%
8,928 $639,000
Q3 2023

Nov 13, 2023
BUY
$52.09 - $64.1 $72,248 - $88,906
1,387 Added 17.33%
9,390 $489,000
Q2 2023

Jul 31, 2023
BUY
$54.67 - $66.44 $4,920 - $5,979
90 Added 1.14%
8,003 $506,000
Q1 2023

May 10, 2023
SELL
$43.8 - $56.99 $29,915 - $38,924
-683 Reduced 7.95%
7,913 $428,000
Q4 2022

Feb 07, 2023
SELL
$44.07 - $54.45 $28,425 - $35,120
-645 Reduced 6.98%
8,596 $454,000
Q3 2022

Nov 14, 2022
BUY
$42.7 - $59.99 $10,632 - $14,937
249 Added 2.77%
9,241 $430,000
Q2 2022

Aug 12, 2022
SELL
$43.0 - $65.64 $105,350 - $160,818
-2,450 Reduced 21.41%
8,992 $513,000
Q1 2022

May 16, 2022
SELL
$38.74 - $62.09 $108,433 - $173,789
-2,799 Reduced 19.65%
11,442 $700,000
Q4 2021

Feb 14, 2022
SELL
$35.2 - $53.42 $23,795 - $36,111
-676 Reduced 4.53%
14,241 $745,000
Q3 2021

Nov 15, 2021
BUY
$28.72 - $42.49 $11,229 - $16,613
391 Added 2.69%
14,917 $556,000
Q2 2021

Aug 13, 2021
BUY
$29.3 - $44.5 $24,524 - $37,246
837 Added 6.11%
14,526 $593,000
Q1 2021

May 14, 2021
SELL
$30.8 - $39.51 $28,058 - $35,993
-911 Reduced 6.24%
13,689 $464,000
Q4 2020

Feb 12, 2021
BUY
$23.34 - $32.22 $2,450 - $3,383
105 Added 0.72%
14,600 $464,000
Q3 2020

Nov 09, 2020
BUY
$17.61 - $31.86 $24,601 - $44,508
1,397 Added 10.67%
14,495 $372,000
Q2 2020

Aug 13, 2020
BUY
$14.35 - $26.64 $14,565 - $27,039
1,015 Added 8.4%
13,098 $336,000
Q1 2020

May 14, 2020
SELL
$12.31 - $33.12 $59,974 - $161,360
-4,872 Reduced 28.73%
12,083 $186,000
Q4 2019

Feb 14, 2020
SELL
$7.26 - $38.49 $7,390 - $39,182
-1,018 Reduced 5.66%
16,955 $582,000
Q3 2019

Nov 13, 2019
BUY
$7.47 - $14.03 $134,258 - $252,161
17,973 New
17,973 $134,000

Others Institutions Holding ITCI

# of Institutions
378
Shares Held
84.7M
Call Options Held
319K
Put Options Held
143K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $8.17B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email